Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01108497 · ClinicalTrials.gov registry record
Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia
A clinical trial, sponsored by Stanford University.
- Terminated
- Registry status
- 235
- Enrollment target
NCT01108497: Clinical Trial study, sponsored by Stanford University.
NCT01108497 is a clinical trial that was terminated before completion, run by Stanford University. The registered enrollment target is 235 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01108497 was terminated before completion, sponsored by Stanford University.
- TERMINATED
- Registry status
- 235 participants
- Enrollment target
Study Summary
We will study gene and protein expression in leukemia cells of children diagnosed with acute leukemia. We hope to identify genes or proteins which can help us grade leukemia at diagnosis in order to: (a) develop better means of diagnosis and (b) more accurately choose the best therapy for each patient.
Interventions
- PROCEDURE Bone Marrow Aspiration
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 235 participants |
| Start Date | 2001-07 |
| Est. Completion | 2015-09 |
Why NCT01108497 stopped before completion
NCT01108497 is an observational study that tracks outcomes without assigning an intervention. The registered 235 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Bone Marrow Aspiration is the first listed.
NCT01108497 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01108497 about?
NCT01108497 is a clinical study titled "Genome, Proteome and Tissue Microarray in Childhood Acute Leukemia". We will study gene and protein expression in leukemia cells of children diagnosed with acute leukemia. We hope to identify genes or proteins which can help us grade leukemia at diagnosis in order to: (a) develop better means of diagnosis and (b) more accurately choose the best therapy for each patie...
What is the current status of trial NCT01108497?
This trial is currently terminated. The enrollment target is 235 participants. The study started on 2001-07. Estimated completion is 2015-09.
What interventions are being tested in trial NCT01108497?
The interventions under investigation include: Bone Marrow Aspiration (PROCEDURE).
Who is sponsoring clinical trial NCT01108497?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01524211 · 235 participants · NA
Evaluation of Branch Endografts in the Treatment of Aortic Aneurysms
- NCT05316155 · 235 participants · Phase 1
Study of Erdafitinib Intravesical Delivery System for Localized Bladder Cancer
- NCT05353569 · 235 participants · NA
Coherent Optical Detection of Middle Ear Disease
- NCT05390918 · 235 participants · NA
Targeting Adolescent Insomnia to Lessen Overall Risk of Suicidal Behavior
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia